Osborne Clarke advised Earlybird, Merieux Equity Partners and NRW.BANK on the deal. Prothea Technologies (Prothea), a private medical technology company spun-out of the Universities of Edinburgh...
Prothea Technologies’ €12 Million Series A Fundraising
Resolve BioSciences’ $71 Million Series B Financing Round
Dechert LLP advised Resolve BioSciences GmbH on the deal. Weitnauer advised NRW.BANK on the deal. Resolve BioSciences GmbH, the pioneer in Molecular Cartography™ technology, closed its...
Emergence Therapeutics’ Series A Financing Round
ARQIS has advised biotech company Emergence Therapeutics AG on the deal, while Horn&Co. advised Pontifax Ventures 6. J&A advised Bpifrance. Weitnauer advised NRW.BANK. The round was...
Gauselmann’s Acquisition of The WestSpiel Group From NRW.BANK
Luther advised Gauselmann, while Hogan Lovells advised NRW.BANK. Gauselmann acquired the WestSpiel Group, the market leader in the German casino market, from NRW.BANK. In May 2018, the...